THC BioMed Intl Ltd. announced that it has appointed Don Shaxon to the company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.